MARKET

EKSO

EKSO

Ekso Bionics
NASDAQ
1.180
+0.020
+1.72%
After Hours: 1.220 +0.04 +3.39% 16:39 04/24 EDT
OPEN
1.160
PREV CLOSE
1.160
HIGH
1.220
LOW
1.160
VOLUME
25.89K
TURNOVER
0
52 WEEK HIGH
3.129
52 WEEK LOW
0.6200
MARKET CAP
21.13M
P/E (TTM)
-1.0766
1D
5D
1M
3M
1Y
5Y
Ekso Bionics Holdings Inc <EKSO.OQ> expected to post a loss of 16 cents a share - Earnings Preview
Ekso Bionics Holdings Inc expected to post a loss of 16 cents a share. The company is expected to report a 21.1% increase in quarterly revenue to $4.993 million. The one available analyst rating on the shares is 'buy' for the company.
Reuters · 1d ago
Weekly Report: what happened at EKSO last week (0415-0419)?
Weekly Report · 2d ago
Weekly Report: what happened at EKSO last week (0408-0412)?
Weekly Report · 04/15 10:29
Weekly Report: what happened at EKSO last week (0401-0405)?
Weekly Report · 04/08 10:32
Weekly Report: what happened at EKSO last week (0325-0329)?
Weekly Report · 04/01 10:32
Weekly Report: what happened at EKSO last week (0318-0322)?
Weekly Report · 03/25 10:34
Weekly Report: what happened at EKSO last week (0311-0315)?
Weekly Report · 03/18 10:32
Cognition Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern about the company's prospects. Blue Star Foods Corp. And Ekso Bionics Holdings have recently had notable insider transactions for penny stocks. The Dow Jones index closed lower by more than 100 points on Thursday.
Benzinga · 03/15 11:13
More
About EKSO
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.

Webull offers Ekso Bionics Holdings Inc stock information, including NASDAQ: EKSO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EKSO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EKSO stock methods without spending real money on the virtual paper trading platform.